Skip to main content

Concert Pharmaceuticals, Inc.

CNCEDelisted Mar 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001367920

Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Concert Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
+1 vs. Q4 2021
Shares held
17.2M
−927.6K (−5.1%) vs. Q4 2021
Total value
$58.0M
+$881.8K (+1.5%) vs. Q4 2021
New holders
9
7 more added
Sold out
8
24 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 53 institutions
Q1 2021: 91 institutionsQ2 2021: 79 institutionsQ3 2021: 61 institutionsQ4 2021: 52 institutionsQ1 2022: 53 institutionsQ2 2022: 70 institutionsQ3 2022: 80 institutionsQ4 2022: 85 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $58.0M
Q1 2021: $103.6MQ2 2021: $77.2MQ3 2021: $57.1MQ4 2021: $57.1MQ1 2022: $58.0MQ2 2022: $126.5MQ3 2022: $227.2MQ4 2022: $207.2MQ1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CNCE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 202285$207.2M
Q3 202280$227.2M
Q2 202270$126.5M
Q1 202253$58.0M
Q4 202152$57.1M
Q3 202161$57.1M
Q2 202179$77.2M
Q1 202191$103.6M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Concert Pharmaceuticals, Inc.; share changes are against Q4 2021.

Institutions holding CNCE in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.3,033,603$10.2M0.22%00.0%Unchanged
BVF Inc2,253,000$7.59M0.30%00.0%Unchanged
Perceptive Advisors LLC2,150,641$7.25M0.15%00.0%Unchanged
Ingalls & Snyder LLC1,317,423$4.44M0.20%−41,150−3.0%Reduced
Millennium Management LLC1,245,412$4.20M0.01%−103,817−7.7%Reduced
Bank of America Corp1,006,959$3.39M0.00%−2990.0%Reduced
Vanguard Group Inc878,161$2.96M0.00%−336,455−27.7%Reduced
Acadian Asset Management LLC794,106$2.67M0.01%+11,293+1.4%Added
Dimensional Fund Advisors LP778,596$2.62M0.00%+63,860+8.9%Added
Alyeska Investment Group, L.P.548,090$1.85M0.02%00.0%Unchanged
BlackRock Inc.447,948$1.51M0.00%−3,441−0.8%Reduced
Renaissance Technologies LLC426,305$1.44M0.00%−149,500−26.0%Reduced
Parkman Healthcare Partners LLC377,399$1.27M0.37%+377,399New
NewEdge Wealth, LLC336,975$1.14M0.05%−44,351−11.6%Reduced
Connor, Clark & Lunn Investment Management Ltd.333,758$1.13M0.01%−1,287−0.4%Reduced
Geode Capital Management, LLC253,184$853.0K0.00%−3,959−1.5%Reduced
Northern Trust Corp99,232$334.0K0.00%−1,326−1.3%Reduced
Bridgeway Capital Management, LLC93,200$314.0K0.01%−55,000−37.1%Reduced
RBF Capital, LLC71,101$262.0K0.02%−3,522−4.7%Reduced
Kensington Investment Counsel, LLC76,749$259.0K0.17%−8,734−10.2%Reduced
State Street Corp75,798$255.0K0.00%+5,058+7.2%Added
Morgan Stanley68,107$229.0K0.00%−210,629−75.6%Reduced
Two Sigma Advisers, LP65,600$221.0K0.00%−29,800−31.2%Reduced
Black Diamond Financial, LLC46,000$155.0K0.05%00.0%Unchanged
Tudor Investment Corp Et Al45,688$154.0K0.00%00.0%Unchanged
Barclays PLC43,654$147.0K0.00%00.0%Unchanged
Lake Street Advisors Group, LLC35,398$119.0K0.01%00.0%Unchanged
D. E. Shaw & Co., Inc.32,547$110.0K0.00%−12,772−28.2%Reduced
Assenagon Asset Management S.A.31,931$108.0K0.00%−110,033−77.5%Reduced
Tower Research Capital LLC (TRC)25,007$84.0K0.00%+11,316+82.7%Added
Charles Schwab Investment Management Inc23,681$80.0K0.00%+23,681New
Citadel Advisors LLC20,393$69.0K0.00%−54,891−72.9%Reduced
Birchview Capital, LP20,000$67.0K0.05%00.0%Unchanged
Bank of New York Mellon Corp17,890$60.0K0.00%+250+1.4%Added
Jane Street Group, LLC16,627$56.0K0.00%+16,627New
UBS Group AG16,066$54.0K0.00%−2,383−12.9%Reduced
Susquehanna International Group, LLP15,476$52.0K0.00%+15,476New
HRT Financial LP14,470$48.0K0.00%+14,470New
Virtu Financial LLC13,927$47.0K0.00%+13,927New
Two Sigma Investments, LP12,000$40.0K0.00%−78,900−86.8%Reduced
Flagship Harbor Advisors, LLC10,400$35.0K0.00%00.0%Unchanged
Roanoke Asset Management Corp10,000$34.0K0.01%+10,000New
Simplex Trading, LLC8,468$28.0K0.00%+8,468New
Steward Partners Investment Advisory, LLC1,968$7.00K0.00%−4,009−67.1%Reduced
Captrust Financial Advisors1,394$5.00K0.00%−99−6.6%Reduced
Group One Trading, L.P.1,200$4.00K0.00%+500+71.4%Added
Federated Hermes, Inc.239$1.00K0.00%−2,025−89.4%Reduced
Wells Fargo & Company156$1.00K0.00%+1+0.6%Added
AllSquare Wealth Management LLC150$1.00K0.00%00.0%Unchanged
De Burlo Group Inc200$6740.00%+200New
BNP Paribas Arbitrage, SA108$3640.00%−24,426−99.6%Reduced
JPMorgan Chase & Co42$00.00%00.0%Unchanged
Royal Bank of Canada40$00.00%00.0%Unchanged
IndexIQ Advisors LLC0$00.00%−84,631−100.0%Sold out
Marshall Wace, LLP0$00.00%−45,383−100.0%Sold out
Truist Financial Corp0$00.00%−20,000−100.0%Sold out
Algert Global LLC0$00.00%−19,300−100.0%Sold out
XTX Topco Ltd0$00.00%−14,305−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−12,254−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−10,921−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−10,536−100.0%Sold out